$3.26
▲ +$0.02
(+0.62%)
Vol 392K
Wall Street Consensus
7 analysts · Dec 20252
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
GALT
Galectin Therapeutics Inc
$268.2M
ACHV
Achieve Life Sciences Inc
$264.6M
SGMT
Sagimet Biosciences Inc
$183.5M
CNTB
Connect Biopharma Holdings Ltd
$157.6M
PRLD
Prelude Therapeutics Inc
$164.2M
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
NKTX
Nkarta Inc
$131.4M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2023 | $-19.13 | $-10.70 | +$8.43 |
| Sep 2023 | $-22.95 | $-41.25 | $-18.30 |
| Jun 2023 | $-61.20 | $-60.00 | +$1.20 |
| Mar 2023 | $-42.08 | $-86.25 | $-44.18 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$3.8M | -$3.8M | -$2.5M | -$1.9M | -$2.1M |
Financial Health
Free Cash Flow
-$1.9M
Net Debt
-$7.4M
Cash
$7.6M
Total Debt
$161K
As of Sep 30, 2025
Peer Comparison
| Ticker | Mkt Cap | P/E | P/S | ROE | Margin | Beta |
|---|---|---|---|---|---|---|
| CNTN | — | — | — | — | — | — |
| GALT | $268.2M | — | — | -258.6% | — | 1.03 |
| ACHV | $264.6M | — | 14.8 | -196.7% | -94.7% | 1.88 |
| SGMT | $183.5M | — | — | -42.4% | — | 2.75 |
| CNTB | $157.6M | — | 6.0 | -62.7% | -175.2% | -0.18 |
| PRLD | $164.2M | — | — | -51.0% | — | 0.98 |
| ARTV | $105.3M | — | — | -50.0% | — | 1.42 |
| RNAC | $187.5M | — | 97.3 | -3215.8% | -2489.8% | 0.49 |
Top Holders
Top 5: 13.03%ARK Investment Management, …
6.31%
$10.3M
Clear Street Group Inc.
3.25%
$5.3M
Blackrock Inc.
1.49%
$2.4M
Vanguard Group Inc
1.14%
$1.9M
Feynman Point Asset Managem…
0.84%
$1.4M
As of Dec 31, 2025
Latest News
No related news yet